Dashboard › Demo Universe › Evergreen Physician Group

Evergreen Physician Group · EVPG

DEMO DATAUNDERWRITING ASSUMPTIONHOLD
DEMO DATA — fictional company with illustrative numbers.

Roll-up of specialty physician practices, margins squeezed by payer rate changes and labor costs.

Recommendation
HOLD
2 core test(s) failed
Credit score
49 / 100
Elevated
Base IRR
11.0%
vs hurdle 12.0%
Downside IRR
10.3%
default case
Severe recovery
65%
IRR 2.4%
Net leverage
6.2x
FY2025A
EBITDA / interest
1.83x
FY2025A
Open high-priority DD
3

Overview

Sector / industryHealthcare / Physician Practice Management
HeadquartersNashville, TN
Revenue (FY2025A)$1.9B
EBITDA (FY2025A)$247M
Total debt (face value)$1.6B
Cash$80M
Net debt$1.5B
Asset / collateral base$1.4B
Enterprise value (assumed multiple)$2.3B

Investment thesis UNDERWRITING ASSUMPTION

Margins have declined 150bps in two years and coverage is 1.8x, but the platform is growing and the first-lien loan is trading at a discount. We need to understand organic vs acquired growth and payer-contract exposure before underwriting.

InstrumentFirst-Lien Term Loan
Face value / purchase price / cash investment$100M / 93.0 / $93.5M UNDERWRITING ASSUMPTION
Current yield · yield to maturity9.2% · 11.5%

Key protections

  • Discount on first-lien to par
  • Margin recovery as integration completes

Key risks

  • Payer rate pressure / No Surprises Act
  • Physician retention and labor cost
  • Acquisition integration

Key catalysts

  • Payer contract renewals
  • Revolver maturity Jan 2028

Data-quality notes

  • All figures are fictional and illustrative.
Sources & data lineage (3)
SourceDocumentData typePeriodAccessionDoc dateRetrievedClass
CreditIQ demo datasetEvergreen Physician Group — illustrative financial statements FY2022–FY2025Income statement / cash flowFY2022–FY2025—2026-03-312026-03-31DEMO DATA
CreditIQ demo datasetEvergreen Physician Group — illustrative capital structure & covenantsDebt scheduleAs of 2026-03-31—2026-03-312026-03-31DEMO DATA
CreditIQ demo datasetIllustrative indicative bid marks (% of par)Market price2026-03-31—2026-03-312026-03-31DEMO DATA